Search results for "double-blind method"

showing 10 items of 631 documents

Treatment of tension-type headache with articulatory and suboccipital soft tissue therapy: A double-blind, randomized, placebo-controlled clinical tr…

2013

This study researches the effectiveness of two manual therapy treatments focused on the suboccipital region for tension-type headache. A randomized double-blind clinical trial was conducted over a period of four weeks with a follow-up at one month. Eighty-four patients with a mean age of 39.7 years (SD 11.4) with tension-type headache were assigned to 4 groups which included the following manual therapy treatment: suboccipital soft tissue inhibition; occiput-atlas-axis global manipulation; combination of both techniques; and a control group. The primary assessment consisted of collecting socio-demographic data and headache characteristics in a one-month base period, data such as age, gender…

AdultMaleComplementary and Manual TherapySoft tissue therapymedicine.medical_specialtyAdolescentPhysical Therapy Sports Therapy and RehabilitationPlaceboDouble blindYoung AdultSex FactorsDouble-Blind MethodmedicineHumansPain ManagementTherapy Soft TissueAgedbusiness.industryTension-Type HeadacheRehabilitationAge FactorsPatient AcuitySoft tissueMiddle AgedMusculoskeletal ManipulationsSurgeryIntensity (physics)Clinical trialComplementary and alternative medicineFemaleHeadachesmedicine.symptomManual therapybusinessJournal of Bodywork and Movement Therapies
researchProduct

Understanding symptoms in RYR1-Related Myopathies: A mixed-methods analysis based on participants' experience

2020

Background: In rare diseases such as ryanodine receptor 1-related myopathies (RYR1-RM), health-related quality of life (HRQoL) measures are critically important so clinicians and researchers can better understand what symptoms are most important to participants, with the ultimate goal of finding tangible solutions for them. Objectives: The main objective of this study was to characterize symptoms in individuals with RYR1-RM to inform future research. A secondary objective of this study was to analyze positive and negative sentiments regarding symptoms and treatment effects post N-acetylcysteine (NAC) administration in individuals with RYR1-RM. Methods: The study used a mixed-methods design …

AdultMaleCoping (psychology)medicine.medical_specialtyWeaknessMEDLINEPainQualitative propertyArticleHealth administrationlaw.inventionInterviews as Topic03 medical and health sciences0302 clinical medicineDouble-Blind MethodMuscular DiseasesRandomized controlled triallawAdaptation PsychologicalHumansMedicine030212 general & internal medicineChildFatigueEsportsHealth economicsbusiness.industry030503 health policy & servicesPublic healthRyanodine Receptor Calcium Release ChannelMiddle AgedAcetylcysteineSocioeconomic FactorsQuality of LifeFemaleEducació físicamedicine.symptom0305 other medical sciencebusinessClinical psychology
researchProduct

Platelet aggregation, ATP release and cytoplasmic Ca2+ movement: the effects of cloricromene.

1994

A placebo-controlled, double-blind, randomized, cross-over study was performed in 24 healthy volunteers. 12 volunteers received Cloricromene (100mg gastroresistant capsules twice a day) for 7 days, the other volunteers received identical placebo capsules. Subsequently, after a 7-day wash-out period, at day 15, each subject received the other treatment. Blood samples were taken on days 1 and 15 (1st day of each treatment) as well as on days 7 and 21 (7th day of each treatment) before the morning drug administration and 2 and 4 hours later. Platelet aggregation and ATP secretion were studied in whole blood (WB) using ADP and collagen as stimulating agents. Ca2+ fluxes were studied in aequorin…

AdultMaleCytoplasmAdolescentPlatelet Aggregationchemistry.chemical_elementAdministration OralPharmacologyCalciumPlaceboAdenosine TriphosphateDouble-Blind MethodOral administrationHumansPlateletSecretionWhole bloodCalcium metabolismCross-Over StudiesChemistryChromonarHematologyMiddle AgedCrossover studyAdenosine DiphosphateAnesthesiaCalciumFemaleCollagenPlatelet Aggregation InhibitorsThrombosis research
researchProduct

Chlorhexidine alcohol base mouthrinse versus Chlorhexidine formaldehyde base mouthrinse efficacy on plaque control: Double blind, randomized clinical…

2011

Background: Chlorhexidine is well known for its antiplaque effect. However, the mouthrinse based chlorhexidine antiplaque efficiency may vary according to the formulation of the final product. The aim of the present study was to compare anti-plaque effectiveness of two commercial mouthrinses: 0.12 % Chlorhexidine alcohol base (CLX-A) versus a diluted 0.1% Chlorhexidine non-alcohol base with 0.1% of Formaldehyde (CLX-F). Material and Methods: the study was a seven day randomized, double-blind, placebo-controlled trial including 30 volunteers. At the start, all participants received a dental prophylaxis. Over 7 days experimental non-brushing period, during which subjects abstained from all fo…

AdultMaleDental PlaqueMouthwashesFormaldehydeDentistryOdontologíaAlcoholPlaceboOral hygienePlaque controllaw.inventionDouble blindYoung Adultchemistry.chemical_compoundDouble-Blind MethodRandomized controlled triallawFormaldehydeHumansMedicineGeneral Dentistrybusiness.industryChlorhexidineChlorhexidineClinical and Experimental dentistry:CIENCIAS MÉDICAS [UNESCO]Ciencias de la saludOtorhinolaryngologychemistryUNESCO::CIENCIAS MÉDICASFemaleResearch-ArticleSurgerybusinessDisinfectantsmedicine.drugMedicina Oral Patología Oral y Cirugia Bucal
researchProduct

A double blind controlled trial comparing three treatment modalities for dentin hypersensitivity

2011

Aim: This randomized, double blind, split mouth study was aimed to compare three dentin desensitizing treatment modalities. Methods: Two hundred sixty teeth of 25 patients; each having at least 2 hypersensitive teeth in each quadrant, were included. Teeth were randomized to 4 groups: Group A treated with 2% NaF solution, Group B received GLUMA®; an aqueous solution of Hydroxy-Ethyl-Methacrylate and Glutarldehyde, (HEMA-G), Group C received iontophoresis with distilled water (placebo) and Group D was treated with NaF-iontophoresis. Pain response was evaluated on a visual analogue scale (VAS), by using tactile, air blast and cold-water stimuli at 0-day, 15-day, 1-month and 3-months interval. …

AdultMaleDentin Desensitizing AgentsVisual analogue scaleDentistryPlaceboGroup Blaw.inventionYoung AdultRandomized controlled trialDouble-Blind Methodstomatognathic systemlawmedicineDentinHumansPeriodontologyGeneral DentistryDentin Sensitivitybusiness.industryDentin SensitivityMiddle Agedmedicine.disease:CIENCIAS MÉDICAS [UNESCO]medicine.anatomical_structureOtorhinolaryngologyUNESCO::CIENCIAS MÉDICASDentin Desensitizing AgentsDentin hypersensitivitySurgeryResearch-ArticleFemalebusiness
researchProduct

Evaluation of the analgesic efficacies of Dexketoprofen Trometamol and Dexketoprofen Trometamol + Thiocolchicoside combinations in the impacted third…

2019

Background Postoperative pain is one of the most common complications. The aim of this study is to evaluate the analgesic efficacies of dexketoprofen trometamol and two different dosages of dexketoprofen trometamol + thiocolchicoside combination in the impacted third molar tooth operation. Material and Methods This randomized, double-blind study included 75 patients who did not have any disease. Patients were assigned to 3 groups. Group 1 received 25 mg dexketoprofen trometamol + 4 mg thiocholchicoside, Group 2 received 25 mg dexketoprofen trometamol +8 mg thiocholchicoside, and Group 3 received 25 mg dexketoprofen trometamol. In each group, the analgesic medication was administered twice a…

AdultMaleDoseAdolescentAnalgesiclaw.invention03 medical and health sciencesYoung Adult0302 clinical medicineThird molar surgeryRandomized controlled trialstomatognathic systemDouble-Blind MethodlawMedicineHumans030212 general & internal medicineTromethamineGeneral DentistryVas scorebusiness.industryResearchAnti-Inflammatory Agents Non-SteroidalTooth Impacted030206 dentistryDexketoprofen:CIENCIAS MÉDICAS [UNESCO]Clinical trialOtorhinolaryngologyThiocolchicosideKetoprofenAnesthesiaUNESCO::CIENCIAS MÉDICASSurgeryDrug Therapy CombinationFemaleMolar ThirdOral SurgeryAnalgesiabusinessColchicinemedicine.drugMedicina Oral, Patología Oral y Cirugía Bucal
researchProduct

Treatment of Ulcerative Colitis with Olsalazine and Sulphasalazine: Efficacy and Side-Effects

1988

The effects of olsalazine were studied mainly in patients with ulcerative colitis who were intolerant to sulphasalazine, and for relapse prevention. A crossover design with sulphasalazine, 3 g/day, and olsalazine, 1.5 g/day, was applied to compare the side-effects of each drug and to evaluate their therapeutic efficacy. A total of 41 patients with mild or moderately severe left-sided colitis or proctitis were assigned to a randomized treatment schedule. Olsalazine and sulphasalazine were similar in their therapeutic efficacy. Twelve patients complained of adverse effects while on sulphasalazine and 4 patients during olsalazine treatment (p less than 0.05). It is concluded that olsalazine is…

AdultMaleDrugmedicine.medical_specialtymedia_common.quotation_subjectRelapse preventionGastroenterologyRandom AllocationDouble-Blind MethodInternal medicinemedicineHumansProctitisColitisAdverse effectProctitismedia_commonOlsalazineClinical Trials as Topicbusiness.industryGastroenterologymedicine.diseaseUlcerative colitisCrossover studySulfasalazineAminosalicylic AcidsColitis UlcerativeFemalebusinessmedicine.drugScandinavian Journal of Gastroenterology
researchProduct

Efficacy and tolerability of lasmiditan, an oral 5-HT1F receptor agonist, for the acute treatment of migraine : a phase 2 randomised, placebo-control…

2012

Lasmiditan (COL-144) is a novel, centrally acting, highly selective 5-HT(1F) receptor agonist without vasoconstrictor activity that seemed effective when given as an intravenous infusion in a proof-of-concept migraine study. We aimed to assess the efficacy and safety of oral lasmiditan for the acute treatment of migraine.In this multicentre, double-blind, parallel-group, dose-ranging study in 43 headache centres in five European countries, patients with migraine with and without aura and who were not using prophylaxis were randomly assigned (1:1:1:1:1) to treat one moderate or severe attack at home with 50 mg, 100 mg, 200 mg, or 400 mg lasmiditan, or placebo. Study drug and placebo were sup…

AdultMaleDrug-Related Side Effects and Adverse ReactionsPyridinesPopulationMedizinAdministration OralKaplan-Meier EstimatePlacebolaw.inventionYoung Adult03 medical and health scienceschemistry.chemical_compound0302 clinical medicineDouble-Blind MethodPiperidinesRandomized controlled triallawHumansMedicineAdverse effecteducationAgededucation.field_of_studyDose-Response Relationship Drugbusiness.industryMiddle AgedDose-ranging studymedicine.diseaseLasmiditanSerotonin Receptor Agonists3. Good healthTreatment OutcomechemistryTolerabilityMigraine030220 oncology & carcinogenesisAnesthesiaBenzamidesFemaleNeurology (clinical)business030217 neurology & neurosurgery
researchProduct

Methylphenidate, modafinil, and caffeine for cognitive enhancement in chess: A double-blind, randomised controlled trial.

2017

Stimulants and caffeine have been proposed for cognitive enhancement by healthy subjects. This study investigated whether performance in chess - a competitive mind game requiring highly complex cognitive skills - can be enhanced by methylphenidate, modafinil or caffeine. In a phase IV, randomized, double-blind, placebo-controlled trial, 39 male chess players received 2×200mg modafinil, 2×20mg methylphenidate, and 2×200mg caffeine or placebo in a 4×4 crossover design. They played twenty 15-minute games during two sessions against a chess program (Fritz 12; adapted to players' strength) and completed several neuropsychological tests. Marked substance effects were observed since all three subs…

AdultMaleElementary cognitive taskmedicine.medical_specialtyModafinilAudiologyNeuropsychological TestsPlacebolaw.inventionDevelopmental psychology03 medical and health sciences0302 clinical medicineCognitionRandomized controlled trialDouble-Blind MethodlawCaffeinemedicineHumansPharmacology (medical)Benzhydryl CompoundsBiological PsychiatryRetrospective StudiesPharmacologyAnalysis of VarianceMethylphenidateModafinilNeuropsychologyCognitionWakefulness-Promoting AgentsMiddle AgedCrossover study030227 psychiatryPsychiatry and Mental healthCross-Sectional StudiesNeurologyMethylphenidateCentral Nervous System StimulantsFemaleNeurology (clinical)Psychologyhuman activities030217 neurology & neurosurgerymedicine.drugEuropean neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
researchProduct

Rosuvastatin Prevents Conduit Artery Endothelial Dysfunction Induced by Ischemia and Reperfusion by a Cyclooxygenase-2–Dependent Mechanism

2010

ObjectivesThe purpose of this study was to determine whether single-dose rosuvastatin (40 mg) protects against ischemia and reperfusion (IR)–induced endothelial dysfunction in humans and whether this effect is cyclooxygenase (COX)-2 dependent.BackgroundAnimal studies have demonstrated that rosuvastatin can limit damage and improve recovery after IR.MethodsIn a double-blind, parallel design, 20 volunteers were randomized to a single dose of oral rosuvastatin (40 mg) or placebo. Twenty-four hours later, endothelium-dependent, flow-mediated dilation (FMD) of the radial artery was measured before and after IR (15 min of upper arm ischemia followed by 15 min of reperfusion). In a separate protoc…

AdultMaleEndotheliumendotheliumAdolescentPremedicationIschemiaMyocardial Reperfusion InjuryPharmacologyPlaceboYoung AdultDouble-Blind Methodmedicineischemia reperfusionHumansRosuvastatinEndothelial dysfunctionRosuvastatin CalciumSulfonamidesCyclooxygenase 2 Inhibitorsbusiness.industryModels Cardiovascularnutritional and metabolic diseases3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitormedicine.diseaseFluorobenzenesVasodilationRosuvastatin Calciummedicine.anatomical_structurePyrimidinesCelecoxibCyclooxygenase 2AnesthesiaIschemic Preconditioning MyocardialRadial ArteryCelecoxibIschemic preconditioningPyrazolesFemaleEndothelium VascularHydroxymethylglutaryl-CoA Reductase InhibitorsbusinessCardiology and Cardiovascular Medicinerosuvastatinmedicine.drugJournal of the American College of Cardiology
researchProduct